Recent studies have identified genetic and clinical risk factors for lean NAFLD including the association of the PNPLA3 rs738409 gene35–38, impaired glucose tolerance, and unfavorable adipokine profiles characterized by low adiponectin concentrations37. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.